Test scheme. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Average relative error of τ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Preparation process of concrete joint specimens. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Cohesion correction coefficient. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 18 in each curve fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 29 in each curve fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Fig 9(b) in the straight-line fitting results. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Specimen packaging process. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

The relationship between Δσ_n and τ₁, <i>JRC</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Relationship between τ_<i>i</i> and σ_<i>i</i>. by Zhezhe Zhang (19704587)

“…Under the same <i>JRC</i>, σ_<i>i</i> increases with the increase of τ₁, and Δσ_n decreases with the increasing τ₁. Under the same <i>JRC</i> and σ_<i>i</i>, τ_<i>i</i> is significantly smaller under the UNLCSL path than the CNL path. …”

Table_2_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.xlsx by Kristin R. Anderson (5478734)

Image_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.jpg by Kristin R. Anderson (5478734)

Table_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.pdf by Kristin R. Anderson (5478734)

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Prolonged starvation leads to a delay in cell cycle re-entry and decrease in H3K27ac in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

“…During starvation (T_5ds, T_20ds), MFI levels of H3K27ac progressively decreased <b>(F)</b> while levels H3K27me3 did not change significantly <b>(G)</b>. …”

Flowchart of the screening process. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Characteristics of included reviews. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”